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SOMMARIO
Insorgenza precoce della Mirror Syndrome associata
con il teratoma fetale sacro coccigeo: un evento raro.
Nella mirror syndrome, i segni e sintomi materni
mimano la condizione di edema fetale e placentare.
La patogenesi del fenomeno non è ancora conosciu-
ta. I fattori etiologici più comunemente implicati so-
no l’isoimmunizzazione materno-fetale, la sindrome
tra trasfusione feto-fetale e alcune infezioni virali.
Pochi sono i casi descritti associati alla presenza di
un tumore fetale ed in particolare ad un teratoma
sacro coccigeo (SCT). Dai dati presenti in letteratura
risulta che l’associazione di SCT con placentomega-
lia e idrope esita generalmente nella morte fetale;
inoltre, va considerato che l’intervento chirurgico
non viene proposto per i feti idropici prima delle 26
settimane di gestazione. Quando si manifesta il qua-
dro di mirror syndrome, l’unico trattamento defini-
tivo è il parto; in tal senso, quindi, si supporta la
gravidanza finchè il parto non diviene necessario
per indicazione materna o il feto raggiunge le 30 set-
timane di gestazione. Riportiamo un caso di mirror
syndrome instauratasi precocemente in presenza di
un voluminoso teratoma sacro coccigeo fetale e
idrope.
Key words: mirror syndrome, Ballantyne syndro-
me, Teratoma Sacrococcigeo, idrope fetale, placen-
tomegalia.
ABSTRACT
Early onset Mirror Syndrome associated with foetal
sacrococcigeal teratoma: a rare entity.
AIn the mirror syndrome, maternal symptoms
mime foetal and placental oedema. The pathogene-
sis is unknown. The most common etiologic associ-
ations are rhesus isoimmunization, twin-twin
transfusion syndrome and viral infections. Few re-
ports are associated to foetal tumors and particular-
ly to sacroccoccigeal teratoma (SCT). Based on sev-
eral published series, foetal SCT with placen-
tomegaly and hydrops is almost universally fatal;
foetal surgery is not typically offered for hydropic
foetuses beyond 26 weeks of gestational age. Deliv-
ery of the foetus is the choise treatment when mir-
ror syndrome is present with supporting the preg-
nancy until delivery is necessary for maternal indi-
cations or the foetus is 30 weeks old. The manage-
ment of a patient with large foetal sacrococcygeal
teratoma, hydrops foetalis and early onset mirror
syndrome is presented.
Key words: mirror syndrome, Ballantyne syn-
drome, sacrococcygeal teratoma, hydrops foetalis,
placentomegaly.
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INTRODUCTION
In 1892, John W. Ballantyne first de-
scribed serious maternal oedema in preg-
nancy associated with fetal hydrops (skin
oedema, ascites, pleural and pericardial ef-
fusion) and placentomegaly due to rhesus
isoimmunization (1). This syndrome is de-
fined as mirror syndrome as the mother’s
symptoms mirror the general edema pre-
sented by compromised foetus and placenta
(2). Today, this pathology is also defined as
Ballantyne syndrome, pseudotoxemia, ma-
ternal hydrops syndrome or triple edema.
Given the rarity of the phenomenon, it is
very difficult to determine the true inci-
dence of mirror syndrome.
Pathogenesis is still unknown and the re-
lationship with foetal hydrops is undefined
(3, 4). After the first case related to rhesus al-
loimmunization, other causes of foetal and
placental hydrops have been associated
with the disease, such as viral infection (Cy-
tomegalovirus or Parvovirus B19 infec-
tions), foetal malformations, foetal or pla-
cental tumors, and twin-twin transfusion
syndrome. 
It is difficult to make a distinction be-
tween mirror syndrome and preeclampsia
as they have many characteristics in com-
mon (5). In this manuscript, we describe a
case of mirror syndrome that was associated
with a growing foetal sacrococcygeal ter-
atoma (SCT), diagnosed and managed at
our Department. 
CASE REPORT
A 37-year-old woman, gravida 0, para 0,
group 0 rhesus-positive, was tranferred
from another hospital at 24 weeks and 3
days of gestation to our Department due to
the foetus having a voluminous SCT, car-
diomegaly, a dilated inferior and superior
vena cava, scalp oedema, hydrothorax, ini-
tial cardiovascular failure with foetal ane-
mia secondary to third space fluid shifting.
On admission, physical examination re-
vealed a relatively good general state, nor-
mal blood pressure (110/70 mmHg),
weight,  63.5 Kg and body temperature, 37.5
°C. She had no history of tobacco, alcohol or
drug abuse. 
Abdominal examination showed a gravid
uterine fundus equivalent to gestational age.
On physical examination, the pregnant
woman exhibited peripheral oedema.
A fetal ultrasound showed an 11.0 x 8.4
cm fetal SCT (type 1, or peduncolated) that
appeared vividly vascularized by high cal-
iber vessels, and polyhydramnios; cardiac ac-
tivity and active fetal movements were pre-
sent. Middle cerebral artery, umbilical artery
and venosus ductus flow was normal. Foetal
biometry corresponded to gestational age. 
Maternal laboratory tests revealed mild
anemia (hemoglobin 8.8 gr %, hematocrit
26.8%), hypoalbumiemia (2.7 g/dL) and
mild proteinuria. Renal (creatinine 0.66
mg/dl, uric acid 5.0 mg/dl) function was
normal. Liver tests (alanine transaminase 61
U/l, aspartate transaminase  48 U/l) were
mildly elevated. Other maternal signs and
symptoms such as oliguria, headache, visu-
al disturbances and low platelets were ab-
sent. Studies on foetal thalassemia, Par-
vovirus B19, Coxakie were all normal. Am-
niocentesis showed a normal karyotype.
TORCH serology was negative. The patient
started therapy with albumine (1 fl x2/die)
after hospitalization.
Conception was spontaneous; the patient
and her husband were not consanguineous,
were apparently healthy and there was no
family history of congenital malformations. 
In consideration of peripheral edema,
hypoalbuminemia, proteinuria, normal
blood pressure, hemodiluition and the evi-
dence at US examination, a diagnosis of mir-
ror syndrome was made. Patient continued
albumin administration and was treated
with antibiotics for suspected cystitis; in ad-
dition, small doses of analgesic were used to
mitigate her discomfort. After counseling, it
was decided to continue observation and
carry on with the pregnancy for as long as
maternal clinical conditions consented. 
Two days after admission, the patient
presented dyspnea, chest pain, mild fever
(37.5°) and a need for oxygen. Contem-
porarily, she developed an increased pe-
ripheral oedema, reduction of diuresis and
spoke of asthenia; she was normotensive
with sinusal rhythm. Echocardiogram
showed a mild mitral and tricuspid failure.
Laboratory investigations showed regular
renal function, but worsening anemia (7.3
g/dl) and hypoalbuminemia (2 g/dl). Given
the clinical picture it was decided to start di-
uretic therapy.
Foetal echocardiography showed an in-
crease of pericardial effusion and foetalis
hydrops. Fewer fetal movements were ob-
served. Fetal prognosis was estimated by
the obstetrical and pediatric staff to be very
poor, due to congestive heart failure. Given
the development of generalized maternal
oedema and the onset of labour pains, the
decision for vaginal delivery was taken. An2
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epidural anesthesia was induced at the L3-4
vertebral interspace without complication.
During labour, fetal cardiac activity was
suddently no longer seen. 
At 24 weeks 6 days of gestation, a girl,
1,350 g, was spontaneously delivered, dead
(Figure 1). The placenta was cm 16 x 16, and
weighed 570 g. The fetus showed a multi-
lobed neoformation in the sacrococcygeal
area (14x10x6 cm) partially covered by anal
skin and perineum, with anterior displace-
ment of the anus. There was hydrops and hy-
drothorax. The heart had atrial situs solitus,
with concordant atrioventricular and ventric-
ular-arterial connections. There was heart dis-
ease characterized by parachute mitral valve.
Situs viscerus addominalis solitus.
After delivery of the foetus, maternal
blood pressure was normal, proteinuria dis-
appeared, and liver function tests returned to
normal by the 5th day. Therapy with albumin
was continued, small doses of diuretics were
administered to reduce the generalized oede-
ma. On the 7th day maternal oedema resolved
and the patient was then discharged.
DISCUSSION
The most consistent clinical characteris-
tics of mirror syndrome are maternal hyper-
tension, generalized edema, and proteinuria
associated with fetal hydrops and placental
enlargement (6). The gestational age in
which the disorder usually appeared ranges
from 22 to 28 weeks of gestation in the liter-
ature (7). The incidence of mirror syndrome
and its mechanism are still unknown and
the relationship with fetal hydrops is not
well understood (4). Furthermore, recent
data suggests that placental hydrops alone
may also cause the syndrome (8, 9). 
Causes of hydrops fetalis are myriad,
ranging from immune to structural to meta-
bolic. Definitive treatment for mirror syn-
drome is delivery of the fetus, regardless of
gestational age, or correction in utero of the
causes of hydrops (6). This often leads to a
resolution of maternal symptoms together
with an improvement in perinatal outcome:
there have been cases in which the sponta-
neously or selective loss of a hydropic twin
resulted in a pregnancy with good maternal
and perinatal outcome (10).
Mirror syndrome which is related to fetal
hydrops and large placental mass has several
clinical characteristics, but maternal oedema,
as in our case, seems to be a key symptom.
Arterial hypertension represents the sec-
ond most common symptom (58% of cases)
associated with mirror syndrome and ex-
plains the difficulty in differentiating this
syndrome from preeclampsia. On the other
hand, one critical clinical distinction is that
mirror syndrome is associated with hemod-
iluition, whearease hemoconcentration is a
typical pathophysiological feature in
preeclampsia (11). Furthemore, preeclampia
diagnosis before 24 week’s gestation is ex-
tremly rare. Our case report is an anomaly
compared to the main data in literature as
our patient did not develop hypertension,
not even post-partum. Instead, she present-
ed hemodilution, polyhydramnios, protein-
uria, and progressive shortness of breath.
This data was useful in making the differen-
tial diagnosis.
In preeclampsia, there is phatogenic evi-
dence of placental underperfusion caused 3
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Figure 1 - Dead hydropic foetus at the time of deli-
very.
by failure of trophoblastic invasion into the
spiral artery, which suggests an angiogenet-
ic modulator involment in this disease (12).
With regard to this aspect, recent studies
have shown that the imbalance between an-
giogenic and antiangiogenic factors might
be responsible for maternal clinical symp-
toms also in mirror syndrome. In particular,
the authors found increased circulating sFlt-
1 (soluble fms-like tyrosine kinase-1) and
sEng (soluble endoglin) levels and de-
creased PlGF (free placental growth factor)
levels in maternal blood at diagnosis of mir-
ror syndrome; this has already been ob-
served in preeclampsia (13, 14). Mirror syn-
drome shares a common hypotesis with
preeclampsia in that the dysfuctional pla-
centa releases anti-angiogenic factors into
the maternal circulation. The relationship
beetwen incresead anti-angiogenic circulat-
ing factors and mirror syndrome is support-
ed by Llurba et al, who describe normaliza-
tion of levels after treatment, and resolution
of fetal hydrops (12).
Only two published studies have looked
specifically at the placental expression of
antiangiogenic factors, demostrating more
intense immunostaining for VEGFR1 and
Endoglin in the syncytiotrophoblast of pla-
centa with mirror syndrome compared to
normal placental tissue (15, 16). 
Hydrops is believed to be a manifesta-
tion of foetal hearth failure, which is associ-
ated with placentomegaly and villous ede-
ma, with an impaired placental exchange.
Throfoblast hypoxia could be associated
with the increased output of angiogenic fac-
tors, such as Flt-1, that initiate a series of
events which could lead to maternal en-
dothelial injury and the clinical picture of
mirror syndrome. These data suggest that
an anti-angiogenic state, similar to that of
preeclampsia, induce ‘mirror manifesta-
tion’, regardless of the specific causes of fe-
tal hydrops. This observation opens new
scenarios for a deeper understanding of the
disease and for its management.
SCT is the most common fetal tumour,
but is a rare condition and is benign in 90%
of cases (17). Large or rapidly growing tu-
mours are associated with a poor prognosis
in relation to the development of high out-
put cardiac failure due to the large artero-
venous shunt (18). Based on several pub-
lished series, foetal SCT with placen-
tomegaly and hydrops is almost universally
fatal and for this reason foetuses affected
with SCT are observed very closely to facil-
itate intervention before the development of
hydrops (19). Generally, there are 2 options
for survival for the foetus with SCT and
non-immune hydrops: in utero intervention
for foetuses with pulmonary immaturity
precluding delivery or delivery after 30
weeks with postnatal resection (20). In utero
surgery may be attempted to arrest the vas-
cular shunt due hysterotomy with tumour
debulking or radiofrequency ablation of the
main blood supply (17).
Outcomes for the 26-to-30-week gesta-
tional age foetus with SCT and late hydrops
are poorly defined. Although it has been
demonstrated that infant hydrops is re-
versible after postnatal resection, only one
report has confirmed a successful long-term
outcome in an infant of this gestational age
(19). Foetal SCT with hydrops complicated
by the development of maternal mirror syn-
drome, must necessarily consider the bal-
ance between maternal and foetal wellbe-
ing, and in presence of maternal degenera-
tion, delivery is mandatory. In our experi-
ence, maternal clinical worsening made de-
livery necessary, regardless of gestational
age of the foetus.
In literature, there have been cases in
which foetus cannot be delivered vaginally
due to the size of the teratoma (18). In our
case, the tumour had a maximal dimension
of 14 cm but a vaginal delivery was decided
for, considering other options more risky for
the mother. 
There are few cases of foetal SCT and hy-
drops associated with maternal mirror syn-
drome in medical literature. Finamore et al.
described the first case report in which a
foetus with SCT at 29+5 weeks started to
show an enlarged heart, thickened placenta
and mild polyhydramnion. Later, the classic
symptoms of maternal mirror syndrome ap-
peared.  A caesarean section was performed
at 30 weeks, along with surgical treatment4
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